Aemetis (NASDAQ:AMTX) Share Price Passes Below Two Hundred Day Moving Average – Should You Sell?

Aemetis, Inc (NASDAQ:AMTX) crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $2.02 and traded as low as $1.47. Aemetis shares last traded at $1.50, with a volume of 469,244 shares changing hands.

Analyst Ratings Changes

Several brokerages have recently issued reports on AMTX. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Aemetis in a research note on Wednesday, January 21st. Ascendiant Capital Markets reduced their target price on shares of Aemetis from $21.00 to $20.00 and set a “buy” rating for the company in a report on Wednesday, November 19th. Three investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Aemetis presently has a consensus rating of “Moderate Buy” and an average target price of $17.00.

Aemetis Trading Down 2.0%

The stock has a market cap of $97.31 million, a price-to-earnings ratio of -0.91 and a beta of 2.66. The company has a fifty day simple moving average of $1.52 and a 200-day simple moving average of $2.01.

Institutional Investors Weigh In On Aemetis

Several hedge funds have recently made changes to their positions in the company. Vanguard Personalized Indexing Management LLC grew its holdings in shares of Aemetis by 48.7% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 19,611 shares of the specialty chemicals company’s stock valued at $49,000 after buying an additional 6,420 shares in the last quarter. Ethic Inc. acquired a new stake in Aemetis during the 2nd quarter worth about $42,000. R Squared Ltd acquired a new stake in Aemetis during the 2nd quarter worth about $30,000. Graham Capital Management L.P. purchased a new position in Aemetis during the 4th quarter valued at about $45,000. Finally, Caitong International Asset Management Co. Ltd purchased a new position in Aemetis during the 4th quarter valued at about $49,000. Hedge funds and other institutional investors own 27.02% of the company’s stock.

About Aemetis

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.